Viridian Therapeutics

WALTHAM, Mass., June 26, 2026 Viridian Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved Lumvoa™...

WALTHAM, Mass., United States – May 5, 2026 Viridian Therapeutics Inc. has announced positive topline results from its Phase...